Big fish in small ponds: Narrow repertoires of stem-like tissue-resident T cells yield great power in anti-tumor immunity
- PMID: 35705001
- DOI: 10.1016/j.immuni.2022.05.017
Big fish in small ponds: Narrow repertoires of stem-like tissue-resident T cells yield great power in anti-tumor immunity
Abstract
Metastatic ovarian cancer is a significant clinical challenge due in part to its poor response to immunotherapy. In a recent issue of Cancer Cell, Anandon et al. (2022) identify a population of stem-like tissue-resident memory T cells that are responsible for the bulk of anti-tumor T cell immunity, with insights into improving therapeutic response.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests K.N.S. is co-inventor of a patent related to identification of neoantigen-specific T cells (MANAFEST – A Novel Sensitive, Specific, Salable and Simple Method to Identify Functional Anti-Tumor T cell Responses, US provisional patent application no. 62/407,820); owns founders equity in ManaT Bio, Inc.; receives commercial research funding from Bristol-Myers Squibb, AstraZeneca, and Enara Bio; and has received travel support/honorari from Illumina, Inc. and Adaptive Biotechnologies. These arrangements have been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.
Comment on
-
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells.Cancer Cell. 2022 May 9;40(5):545-557.e13. doi: 10.1016/j.ccell.2022.03.008. Epub 2022 Apr 14. Cancer Cell. 2022. PMID: 35427494 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources